Results 221 to 230 of about 279,139 (356)

Primary Cardiac T-cell Lymphoma Presenting as ST-elevation Myocardial Infarction with Fatal Ventricular Arrhythmias: A Case Report

Alaa Jamal AlObaidli, Muhammad Azam Shah, Abdullah Alkhodair, Halia Zain Alshehri, Mohmmed Alhumaid   +4 more
openalex   +1 more source

Immune Modulation of Cardiac Arrhythmias [PDF]

, 2017
Barry London
openalex   +1 more source

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

ESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García, Teresa López‐Sobrino, Esther Sanz‐Girgas, Maria R. Cueto, Jaime Aboal, Pablo Pastor, Irene Buera, Alessandro Sionis, Rut Andrea, Judit Rodríguez‐López, Jose Carlos Sánchez‐Salado, Carlos Tomas, Jordi Bañeras, Albert Ariza, Josep Lupón, Antoni Bayés‐Genís, Ferran Rueda, Grup de Treball de Cures Agudes Cardiològiques Societat Catalana de Cardiologia   +17 more
wiley   +1 more source

Cardiac arrhythmias in cancer patients using the nationwide claim-based database in Japan. [PDF]

J Arrhythm
Kobayashi T, Kusano K.
europepmc   +1 more source

Ventricular Arrhythmias in a Unexpected Cardiac Magnetic Resonance

Raimondo Pittorru, Donatella Tansella, Alberto Cipriani, De Conti Giorgio, Manuel De Lazzari, Stefania Rizzo, Monica De Gasperi, Federico Migliore, Cristina Basso, Sabino Iliceto, Martina Perazzolo Marra   +10 more
openalex   +1 more source

Heart failure in two male patients with late‐onset Fabry mutation (IVS4 + 919G > A)

ESC Heart Failure, Volume 12, Issue 2, Page 1508-1513, April 2025.
Xufei Yang, Chunlan Deng, Xiaogang Guo, Hui Yan   +3 more
wiley   +1 more source

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

ESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen, Jiahao Shi, Yue Wu, Lizhu Miao, Zilin Wang, Yixuan Wang, Siwei Xu, Yu Lou   +7 more
wiley   +1 more source

Inflammatory cytokines and cardiac arrhythmias: from pathogenesis to potential therapies. [PDF]

Ann Med Surg (Lond)
Obeagu EI.
europepmc   +1 more source

Efficacy and Safety of Amiodarone and Propranolol in Pediatric Cardiology for Arrhythmia After Cardiac Surgery: A Retrospective Design Study [PDF]

Amr Shaher Ahmed Almomani, Mohammad A Obeidat, Mohammad Harbi Khassawneh, Sakher M Maayeh, Khaled N Al-Malouf   +4 more
openalex   +1 more source

Theory and practice of present clinical use of Quinidine in the management of cardiac arrhythmias. [PDF]

Indian Pacing Electrophysiol J
Belhassen B, Milman A.
europepmc   +1 more source